COMPANY PROFILE

DESITIN ARZNEIMITTEL GmbH was founded in Berlin in 1919. We developed and successfully introduced the still frequently u ...

Click to Expand
TERRITORIES

Desitin concentrates its marketing efforts on the European continent. In a number of countries (key countries mainly in ...

Click to Expand
PROMOTED PRODUCTS

Desitin is focused on pharmaceuticals for the treatment of epilepsy. It is the only manufacturer that offers the almost ...

Click to Expand
PRODUCT AVAILABILITY BY COUNTRIES

Three active ingredients play a major role in Desitin‘s own developments for epilepsy: Valproic acid, which is the fir ...

Click to Expand
OUR HERITAGE

Medium-sized, specialized pharmaceutical company Founded nearly 100 years ago
 in Berlin Independent, family-owned, pr ...

Click to Expand
DESITIN PHARMA DISCLOSURE SUMMARY

Desitin Pharma Ltd disclosure of payments to Health Care Professionals (HCPs), Donations and Grants Date of Preparation ...

Click to Expand
CORPORATE MILESTONES

Pharmaceutical innovations developed by Desitin as well as the launch of new chemical entities licenced from partners r ...

Click to Expand
STRONG REPUTATION

Desitin’s straightforward approach together with the quality of its products from own development and licensors conseq ...

Click to Expand
INNOVATIONS

Desitin Pharmaceuticals GmbH – galenic innovation for over 40 years 2011 Levetiracetam Desitin The first levetiracetam ...

Click to Expand
SUPPLY CHAIN / PRODUCTION

Pharmaceuticals are developed, manufactured, procured, and tested at Desitin’s Hamburg site under modern conditions an ...

Click to Expand
RESEARCH & DEVELOPMENT

Relevant information about our clinical development activities is provided below. At Desitin, we are proud of the fact t ...

Click to Expand
Are you visiting this website as a member of the public or as a medical professional?
Member of the public
Medical Professional